- Current report filing (8-K)
January 02 2009 - 1:03PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 29, 2008
ENDOLOGIX, INC.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
000-28440
|
|
68-0328265
|
|
|
|
|
|
(State or other jurisdiction of
|
|
(Commission File Number)
|
|
(I.R.S. Employer Identification
|
incorporation)
|
|
|
|
No.)
|
|
|
|
11 Studebaker, Irvine, CA
|
|
92618
|
|
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrants telephone number, including area code:
(949) 595-7200
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
o
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
o
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
o
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
|
|
o
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
|
TABLE OF CONTENTS
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of
Principal Officers; Compensatory Arrangements of Certain Officers.
(e)
|
|
On December 29, 2008, Endologix, Inc. (the Company) entered into:
|
|
|
|
an Employment Agreement with John McDermott, the Companys President and Chief
Executive Officer;
|
|
|
|
|
an Employment Agreement with Robert J. Krist, the Companys Chief Financial Officer
and Secretary;
|
|
|
|
|
an Employment Agreement with Stefan G. Schreck, Ph.D., the Companys Vice President,
Technology; and
|
|
|
|
|
an Employment Agreement with Janet Fauls, the Companys Vice President, Regulatory
and Clinical Affairs.
|
The foregoing employment agreements are referred to herein collectively as the Restated
Agreements.
The Company entered into the Restated Agreements for the purpose of bringing the prior
employment agreements between the Company and the above-named officers of the Company into
compliance with the applicable provisions of Section 409A of the Internal Revenue Code of 1986, as
amended, and the Treasury Regulations issued thereunder. Section 409A governs nonqualified deferred
compensation arrangements. Section 409A imposes penalties and additional tax on service providers
(including employees and directors) if a nonqualified deferred compensation arrangement does not
comply with its provisions. Accordingly, the Restated Agreements, among other things, modify the
definitions of change in control and corporate transaction and related termination procedures
to comply with Section 409A, modify the definition of termination for good reason and related
termination procedures to comply with Section 409A, clarify that any severance payments which are
treated as nonqualified deferred compensation must be made upon a separation of service with the
Company and that, subject to certain exceptions, such payments may be delayed for a period of six
months if an officer is deemed to be a specified employee at the time of his or her termination
of employment, and provide that certain payments to the officers, including expense reimbursements,
will be made only at times permissible without triggering tax penalties under Section 409A.
The foregoing description of the Restated Agreements does not purport to be complete and is
qualified in its entirety by reference to the full texts of the Restated Agreements, copies of
which are attached hereto as Exhibits 10.1, 10.2, 10.3 and 10.4 and are incorporated herein by
reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
|
|
|
Exhibit
|
|
|
Number
|
|
Description
|
10.1
|
|
Employment Agreement, dated as of December 29, 2008, between
Endologix and John McDermott.
|
|
|
|
10.2
|
|
Employment Agreement, dated as of December 29, 2008, between
Endologix and Robert J. Krist.
|
|
|
|
10.3
|
|
Employment Agreement, dated as of December 29, 2008, between
Endologix and Stefan G. Schreck, Ph.D.
|
|
|
|
10.4
|
|
Employment Agreement, dated as of December 29, 2008, between
Endologix and Janet Fauls.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
ENDOLOGIX, INC.
|
|
Date: January 2, 2009
|
/s/ Robert J. Krist
|
|
|
Robert J. Krist
|
|
|
Chief Financial Officer
|
|
EXHIBIT INDEX
|
|
|
Exhibit
|
|
|
Number
|
|
Description
|
10.1
|
|
Employment Agreement, dated as of December 29, 2008, between
Endologix and John McDermott.
|
|
|
|
10.2
|
|
Employment Agreement, dated as of December 29, 2008, between
Endologix and Robert J. Krist.
|
|
|
|
10.3
|
|
Employment Agreement, dated as of December 29, 2008, between
Endologix and Stefan G. Schreck, Ph.D.
|
|
|
|
10.4
|
|
Employment Agreement, dated as of December 29, 2008, between
Endologix and Janet Fauls.
|
Endologix (NASDAQ:ELGX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Endologix (NASDAQ:ELGX)
Historical Stock Chart
From Jul 2023 to Jul 2024